GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak - Melissa Bersanelli, Sebastiano Buti, Mimma Rizzo, Alessio Cortellini, Carlo Cattrini, Francesco Massari, Cristina Masini, Maria Giuseppa Vitale ...
Terapie di combinazione: il punto su melanoma, carcinoma polmonare e carcinoma renale - OncoInfo
maugeri - insalutenews.it
Camillio PORTA | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO) | Research profile
Il commissario Maugeri e la Compagnia della Morte - Fulvio Capezzuoli | GoodBook.it
Uterine carcinosarcoma: An overview - ScienceDirect
The role of endothelial colony forming cells in kidney cancer's pathogenesis, and in resistance to anti-VEGFR agents and mTOR inhibitors: A speculative review - ScienceDirect
Numero 3, Luglio-Settembre - Azienda ospedaliera S.Camillo ...
Oncologia Traslazionale | ICS Maugeri
PDF) Simian virus 40-like DNA sequences and large-T antigen-retinoblastoma family protein pRb2/p130 interaction in human mesothelioma
Mirrors of Medicine - PinPoint cases - Esperti e collaboratori
COVID-19: il ruolo degli oncologi - OncoInfo
Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214 - European Urology
Kidney Cancer: What Is New in the Second-Line Treatment Setting?
Press & Media - Capable
Loop | Camillo Porta
SV40 Replication in Human Mesothelial Cells Induces HGF/Met Receptor Activation: A Model for Viral-Related Carcinogenesis of Hum
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas: Expert Opinion on Pharmacotherapy: Vol 21, No 18
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all? - Porta - Annals of Translational Medicine
T:: l pbnoio tor8
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale | Future Oncology
Edgar V. Lerma 🇵🇭 on Twitter: "Renal Cell Carcinoma Staging #Nephpearls https://t.co/3D5YaTBnlJ" / Twitter
Carcinoma renale avanzato: una terapia innovativa in prima linea - OncoInfo
Nefrologia, Chirurgia urologica e ricerche Nanotech: nasce a Pavia l'Oncologia Traslazionale - insalutenews.it
WHICH IMMUNOTHERAPY IS THE STANDARD 1ST LINE THERAPY IN mRCC – IMMUNE COMBOS WITH A TKI
